Piqray (Alpelisib) Tab 150mg C56 Skip to content
Local deliveries in La Paz, Los Cabos, Querétaro, and San Miguel de Allende. National shipping to all of Mexico.
Local deliveries in La Paz, Los Cabos, Querétaro, and San Miguel de Allende. National shipping throughout Mexico

Piqray (Alpelisib) Tab 150mg C56

Sold out
Original price $ 168,436.36
Original price $ 168,436.36 - Original price $ 168,436.36
Original price $ 168,436.36
Current price $ 151,592.73
$ 151,592.73 - $ 151,592.73
Current price $ 151,592.73

La venta de este medicamento requiere receta médica. Su dispensación está sujeta a la validación de la receta y al cumplimiento de la normativa sanitaria vigente. La información contenida en este sitio tiene fines exclusivamente informativos y comerciales, incluyendo la descripción y el precio del producto, y no sustituye la valoración, diagnóstico o prescripción de un profesional de la salud.

SKU 7501124820961
Availability:
Out of stock
Notify me when they have inventory available

¿Necesitas este producto u otro medicamento?

Este producto está agotado por el momento. Nuestros asesores farmacéuticos pueden ayudarte a conseguirlo o encontrar la mejor alternativa para tu tratamiento.

Contáctanos por WhatsApp

Category

Oncologicals

Line

PI3K Pathway Inhibitors

Brand

Piqray

Molecule

Alpelisib

Presentation

150 mg tablets, C56

Laboratory

Novartis

Indications

Piqray (Alpelisib) is indicated for the treatment of adult patients with hormone receptor-positive (HR+) and HER2-negative advanced or metastatic breast cancer, in combination with an aromatase inhibitor, as initial therapy. This medication is indicated for patients whose disease has PIK3CA gene mutations, which can be identified through specific genetic tests. Piqray acts by inhibiting the PI3K signaling pathway, which is crucial for cell growth and proliferation in various malignancies. Treatment efficacy should be periodically evaluated, and patients should be monitored for signs of disease progression or adverse effects.

Composition

Each Piqray tablet contains 150 mg of Alpelisib as the active ingredient. It also contains excipients that facilitate tablet formulation, including lactose monohydrate, microcrystalline cellulose, among others.

Contraindications

Piqray is contraindicated in patients with known hypersensitivity to Alpelisib or any of the excipients in the formulation. It is also contraindicated in patients with severe hepatic impairment and those receiving treatment with strong CYP3A4 inducers.

Precautions

Caution should be exercised in patients with a history of allergic reactions to other medications, as well as in those undergoing dialysis or with moderate liver disease. Regular blood glucose monitoring is important, as Alpelisib can cause hyperglycemia. Drug interactions should also be considered, so it is essential to inform the doctor about all medications the patient is taking.

Storage

The medication should be stored at room temperature, between 15 and 30 degrees Celsius, in a dry place protected from light. Keep out of reach of children.

Consult your doctor

Prescription required

Shipping

  1. Free home delivery by local branches on orders over $1000. Otherwise, a $50 fee will be added in the cities of Querétaro and La Paz, BCS, and $150 in San José del Cabo and Cabo San Lucas, BCS.
  2. FREE national shipping via ground on orders over $1,500.00. Otherwise, a fee of $170.00 MXN (One hundred seventy Mexican pesos) will be added for a standard package with dimensions up to 20cm x 20cm x 20cm and 1kg in weight, and $290.00 MXN (Two hundred ninety Mexican pesos) for packages exceeding the aforementioned dimensions or weight.
  3. In case of oversized items, the corresponding fee will apply according to the parcel service.
  4. Orders received after 2:00 PM will be shipped the next day.
  5. For more details, please consult our shipping policy.

Payment and Security

Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.

Category

Oncologicals

Line

PI3K Pathway Inhibitors

Brand

Piqray

Molecule

Alpelisib

Presentation

150 mg tablets, C56

Laboratory

Novartis

Indications

Piqray (Alpelisib) is indicated for the treatment of adult patients with hormone receptor-positive (HR+) and HER2-negative advanced or metastatic breast cancer, in combination with an aromatase inhibitor, as initial therapy. This medication is indicated for patients whose disease has PIK3CA gene mutations, which can be identified through specific genetic tests. Piqray acts by inhibiting the PI3K signaling pathway, which is crucial for cell growth and proliferation in various malignancies. Treatment efficacy should be periodically evaluated, and patients should be monitored for signs of disease progression or adverse effects.

Composition

Each Piqray tablet contains 150 mg of Alpelisib as the active ingredient. It also contains excipients that facilitate tablet formulation, including lactose monohydrate, microcrystalline cellulose, among others.

Contraindications

Piqray is contraindicated in patients with known hypersensitivity to Alpelisib or any of the excipients in the formulation. It is also contraindicated in patients with severe hepatic impairment and those receiving treatment with strong CYP3A4 inducers.

Precautions

Caution should be exercised in patients with a history of allergic reactions to other medications, as well as in those undergoing dialysis or with moderate liver disease. Regular blood glucose monitoring is important, as Alpelisib can cause hyperglycemia. Drug interactions should also be considered, so it is essential to inform the doctor about all medications the patient is taking.

Storage

The medication should be stored at room temperature, between 15 and 30 degrees Celsius, in a dry place protected from light. Keep out of reach of children.

Consult your doctor

Prescription required